ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

6,936Medicare Part D Prescriptions Filled, Including Refills

Rank: 888 out of 3001

$492K Total Retail Price of All Prescriptions

Rank: 662 out of 3001

124 Patients Receiving at Least One Drug in Part D
54%Patients 65 Years and Older
86% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Ohio
Lower avg

Schedule Two
Controlled Substances

26% of this provider’s 124 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

26% of this provider’s 124 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

2% of this provider’s 3,871 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

39% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$71 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

56 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Ohio
LISINOPRIL 192 111 1 2
NEXIUM 180 104 2 23
PROAIR HFA 175 50 3 30
HYDROCODONE-ACETAMINOPHEN 172 110 S3 4 7
AMLODIPINE BESYLATE 153 126 5 5
SIMVASTATIN 153 62 5 1
OMEPRAZOLE 147 81 7 4
METFORMIN HCL 147 91 7 9
XOPENEX HFA 140 89 9 408
OXYCODONE-ACETAMINOPHEN 130 34 S2 10 32
HYDROCHLOROTHIAZIDE 123 78 11 10
PRAVASTATIN SODIUM 116 67 12 13
SPIRIVA 113 94 13 57
NAPROXEN 112 57 14 84
LEVOCETIRIZINE DIHYDROCHLORIDE 109 77 15 343
CLOPIDOGREL 102 72 16 28
FUROSEMIDE 100 66 17 6
ATORVASTATIN CALCIUM 100 78 17 11
LIDODERM 96 67 19 122
POTASSIUM CHLORIDE 94 66 20 15
OXYCODONE HCL-ACETAMINOPHEN 91 28 S2 21 81
LEVOTHYROXINE SODIUM 86 22 22 3
PLAVIX 83 57 23 46
LISINOPRIL-HYDROCHLOROTHIAZIDE 81 33 24 22
AZITHROMYCIN 79 36 25 36
FLOVENT HFA 77 37 26 285
METOPROLOL TARTRATE 76 76 27 8
CYCLOBENZAPRINE HCL 71 39 R 28 73
LIPITOR 64 59 29 100
PREMARIN 64 13 R 29 214
CELEBREX 62 40 31 89
SINGLE USE SWAB 62 55 31 455
ZOLPIDEM TARTRATE 56 17 33 24
PROMETHAZINE HCL 55 25 R 34 93
SINGULAIR 53 44 35 95
BENICAR 52 40 36 206
CRESTOR 52 40 36 33
CARVEDILOL 51 23 38 25
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 16, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.